Literature DB >> 9749857

Prediction and limitation of hepatic tumor resection without blood transfusion in cirrhotic patients.

C C Wu1, S M Kang, W M Ho, J S Tang, D C Yeh, T J Liu, F K P'eng.   

Abstract

BACKGROUND: The need for blood transfusion in cirrhotic liver resection is difficult to determine because of inaccurate estimation of operative blood loss. Moreover, blood transfusion is detrimental to cirrhotic patients.
OBJECTIVE: To investigate the predictors and limitations of hepatectomy without blood transfusion for cirrhotic patients.
DESIGN: Retrospective study.
SETTING: University hospital, a tertiary referral center. PATIENTS: A consecutive 163 cirrhotic patients underwent resection for liver tumor(s) under a policy of restrictive blood transfusion.
INTERVENTIONS: Estimated blood losses and clinicopathological features of patients who received and those who did not receive a blood transfusion were compared. MAIN OUTCOME MEASURES: Estimated operative blood losses, preoperative assessments, and operative procedures.
RESULTS: There were 48 patients in the group who received a blood transfusion, with 1275 +/- 650 mL (mean +/- SE) of blood transfused, and 115 patients in the group who did not receive a blood transfusion. From discriminant analysis, the cutoff value of estimated blood loss for blood transfusion was 1685 mL. Tumor size and site of hepatectomy were found to be independent variables influencing blood transfusion under logistic regression analysis.
CONCLUSIONS: Most cirrhotic patients tolerate hepatectomy without blood transfusion when the estimated operative blood loss is less than 1600 mL. Hepatectomy can be performed in cirrhotic patients without blood transfusion if the tumor is small (<5 cm), and/or the resection area is confined to Couinaud segments II, III, and VI. In this study, the largest amount of estimated blood loss in cirrhotic liver resection without blood transfusion was 2350 mL, but the uppermost limit remains to be determined.

Entities:  

Mesh:

Year:  1998        PMID: 9749857     DOI: 10.1001/archsurg.133.9.1007

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  10 in total

1.  Advantage of autologous blood transfusion in surgery for hepatocellular carcinoma.

Authors:  Yoshito Tomimaru; Hidetoshi Eguchi; Shigeru Marubashi; Hiroshi Wada; Shogo Kobayashi; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masaki Mori; Hiroaki Nagano
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

2.  Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a "blood transfusion"-free hepatectomy.

Authors:  Cheng-Chung Wu; Wai-Meng Ho; Shao-Bin Cheng; Dah-Cherng Yeh; Mei-Chin Wen; Tse-Jia Liu; Fang-Ku P'eng
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

3.  Assessment of liver stiffness measurement: novel intraoperative blood loss predictor?

Authors:  Min-Soo Kim; Jeong-Rim Lee
Journal:  World J Surg       Date:  2013-01       Impact factor: 3.352

4.  Impact of severe oesophagogastric varices on liver resection for hepatocellular carcinoma in cirrhotic patients.

Authors:  Hsiao-Tien Liu; Shao-Bin Cheng; Cheng-Chung Wu; Hong-Zen Yeh; Chi-Sen Chang; John Wang
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

5.  Post-hepatectomy haemorrhage: a single-centre experience.

Authors:  Aijun Li; Bin Wu; Weiping Zhou; Weifeng Yu; Li Li; Hang Yuan; Mengchao Wu
Journal:  HPB (Oxford)       Date:  2014-07-09       Impact factor: 3.647

6.  Hepatic blood inflow occlusion without hemihepatic artery control in treatment of hepatocellular carcinoma.

Authors:  Shan Jin; Chao-Liu Dai
Journal:  World J Gastroenterol       Date:  2010-12-14       Impact factor: 5.742

Review 7.  Vascular control during hepatectomy: review of methods and results.

Authors:  Vassilios Smyrniotis; Charalampos Farantos; Georgia Kostopanagiotou; Nikolaos Arkadopoulos
Journal:  World J Surg       Date:  2005-11       Impact factor: 3.352

8.  Concomitant Hepatectomy and Atrial Thrombectomy under Cardiopulmonary Bypass versus Staged Hepatectomy in the Treatment for Hepatocellular Carcinoma with Large Right Atrial Tumor Thrombi.

Authors:  Wen-Shan Chao; Ching-Hui Shen; Shao-Ciao Luo; Feng-Hsu Wu; Hao-Ji Wei; Chu-Leng Yu; Cheng-Chung Wu; Yun Yen; Fang-Ku P'eng
Journal:  J Clin Med       Date:  2022-04-12       Impact factor: 4.964

9.  An Electrode Array for Limiting Blood Loss During Liver Resection: Optimization via Mathematical Modeling.

Authors:  R M Strigel; D J Schutt; J G Webster; D M Mahvi; D Haemmerich
Journal:  Open Biomed Eng J       Date:  2010-02-04

10.  Predictors of intraoperative blood loss in patients undergoing hepatectomy.

Authors:  Atsushi Nanashima; Takafumi Abo; Keiko Hamasaki; Kouki Wakata; Masaki Kunizaki; Kazuo Tou; Hiroaki Takeshita; Shigekazu Hidaka; Terumitsu Sawai; Tomoshi Tsuchiya; Takeshi Nagayasu
Journal:  Surg Today       Date:  2012-10-20       Impact factor: 2.549

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.